Pfizer Seeks U.S. Approval; EU Splits on Waivers: Virus Update

Pfizer Inc. and its partner BioNTech SE have asked U.S. regulators for full approval of their vaccine, a milestone in their effort to make the shot a sustainable revenue source that goes well beyond …
( read original story …)

---